ERASCA INC. - COMMON STOCK

1.9500

24-January-25 16:45:00

15 minutes delayed

Stocks

-0.0400

-2.01%

Today's range

1.9300 - 2.1100

ISIN

N/A

Source

NASDAQ

Erasca Announces First Patient Dosed in HERKULES-3, a Phase 1b/2 Gastrointestinal Cancer Master Protocol Evaluating ERAS-007 in Multiple Combinations

22 Sep 2021 08:00:00 By Nasdaq GlobeNewswire
Erasca Announces First Patient Dosed in HERKULES-2 Phase 1b/2 Lung Cancer Master Protocol Evaluating ERAS-007 in Multiple Combinations

09 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Encorafenib Combination

08 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
Erasca Reports Second Quarter 2021 Financial Results and Business Updates

26 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
Erasca Announces Pricing of Upsized Initial Public Offering

15 Jul 2021 21:58:28 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.